Department Directory

  • Kenneth Sherman, MD
  • Professor of Digestive Diseases
  • Academic Office:
    Medical Sciences Building, 6th Floor
    231 Albert Sabin Way
    Cincinnati, OH 45267
  • Clinical Office:
    UC Health Physicians Office - Clifton
    222 Piedmont Ave., 4th Floor
    Cincinnati, OH 45219
  • Phone: 513-558-7200
  • Email: shermake@ucmail.uc.edu

    Research/Clinical Interests:

  • Viral Hepatitis - Molecular Heterogeneity, Diagnosis and Treatment, Liver Disease in HIV Infected Patients, Drug Hepatotoxicity.

    Education/Credentials:

  • Bachelor's Degree: Rutgers University, 1976
  • Doctoral Degree: Rutgers University, 1980
  • Research Fellowship : American Red Cross Blood Research Center , 1982
  • Research Fellowship : American Red Cross Blood Research Center , 1982
  • Medical Degree: George Washington University, 1985
  • Residency: Tripler Army Medical Center , 1988
  • Fellowship: Fitzsimons Army Medical Center , 1991

Board Certifications & Licenses:

  • ACLS Provider
  • Ohio License
  • Colorado License
  • Hawaii License
  • New Jersey License
  • Diplomate, American Board of Internal Medicine
  • Diplomate, American Board of Internal Medicine in Gastroenterology
  • Diplomate, National Board of Medical Examiners

Peer Reviewed Publications (in chronological order):

  • Eckman, M. H., Kaiser, T. E., & Sherman, K. E. (2011). (In Press). The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 52 (11) , 1294-306.
  • Blackard, J. T., Ma, G., Martin, C. M., Rouster, S. D., Shata, M. T., & Sherman, K. E. (2011). (In Press). HIV Variability in the Liver and Evidence of Possible Compartmentalization. . AIDS Research and Human Retroviruses.
  • Taylor, L. E., Holubar, M., Wu, K., Bosch, R. J., Wyles, D. L., Davis, J. A., Mayer, K. H., Sherman, K. E., & Tashima, K. T. (2011). (In Press). Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 52 (6) , 812-8.
  • Blackard, J. T., Welge, J. A., Taylor, L. E., Mayer, K. H., Klein, R. S., Celentano, D. D., Jamieson, D. J., Gardner, L., & Sherman, K. E. (2011). (In Press). HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 52 (5) , 674-80.
  • Schmeltzer, P., & Sherman, K. E. (2010). (In Press). Occult hepatitis B: clinical implications and treatment decisions. . Digestive Diseases and Sciences , 55 (12) , 3328-35.
  • Sulkowski, M. S., Shiffman, M. L., Afdhal, N. H., Reddy, K. R., McCone, J., Lee, W. M., Herrine, S. K., Harrison, S. A., Poordad, F. F., Koury, K., Deng, W., Noviello, S., Pedicone, L. D., Brass, C. A., Albrecht, J. K., & McHutchison, J. G. (2010). (In Press). Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. . Gastroenterology , 139 (5) , 1602-11, 1611.e1.
  • Blackard, J. T., Ma, G., Limketkai, B. N., Welge, J. A., Dryer, P. D., Martin, C. M., Hiasa, Y., Taylor, L. E., Mayer, K. H., Jamieson, D. J., & Sherman, K. E. (2010). (In Press). Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. . Journal of Clinical Microbiology , 48 (11) , 4256-9.
  • Sherman, K. E., Andersen, J. W., Butt, A. A., Umbleja, T., Alston, B., Koziel, M. J., Peters, M. G., Sulkowski, M., Goodman, Z. D., & Chung, R. T. (2010). (In Press). Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). . Journal of Acquired Immune Deficiency Syndromes (1999).
  • Kemmer, N. M., & Sherman, K. E. (2010). (In Press). Hepatitis C-related arthropathy: Diagnostic and treatment considerations. . The Journal of Musculoskeletal Medicine , 27 (9) , 351-354.
  • Sherman, Kenneth E (2010). (In Press). Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. . Annals of the New York Academy of Sciences , 1194 , 136-40.
  • McHutchison, J., Goodman, Z., Patel, K., Makhlouf, H., Rodriguez-Torres, M., Shiffman, M., Rockey, D., Husa, P., Chuang, W., Levine, R., Jonas, M., Theodore, D., Brigandi, R., Webster, A., Schultz, M., Watson, H., Stancil, B., & Gardner, S. (2010). (In Press). Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. . Gastroenterology , 138 (4) , 1365-73, 1373.e1-2.
  • Sherman, K. E., Soriano, V., & Chung, R. T. (2010). (In Press). Human immunodeficiency virus and liver disease: conference proceedings. . Hepatology (Baltimore, Md.) , 51 (3) , 1046-54.
  • Sherman, K. E., Rouster, S. D., Stanford, S., Blackard, J. T., Shire, N., Koziel, M., Peters, M., & Chung, R. T. (2010). (In Press). Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. . The Journal of Infectious Diseases , 201 (5) , 712-9.
  • Dryer, P. D., Limketkai, B. N., Martin, C. M., Ma, G., Sherman, K. E., Taylor, L. E., Mayer, K. H., Jamieson, D. J., & Blackard, J. T. (2009). (In Press). Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. . The Journal of Antimicrobial Chemotherapy , 64 (5) , 945-8.
  • Blackard, J. T., Rouster, S. D., Nady, S., Galal, G., Marzuuk, N., Rafaat, M. M., Daef, E., El Din, S. S., Purcell, R. H., Emerson, S. U., Sherman, K. E., & Shata, M. T. (2009). (In Press). Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. . Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology , 46 (2) , 140-4.
  • Martin, C. M., Welge, J. A., Shire, N. J., Shata, M. T., Sherman, K. E., & Blackard, J. T. (2009). (In Press). Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. . Cytokine , 47 (3) , 194-8.
  • Sherman, K., Belkin, I. M., Friedland, K. D., O'Reilly, J., & Hyde, K. (2009). (In Press). Accelerated warming and emergent trends in fisheries biomass yields of the world's large marine ecosystems. . Ambio , 38 (4) , 215-24.
  • Poynard, T., Colombo, M., Bruix, J., Schiff, E., Terg, R., Flamm, S., Moreno-Otero, R., Carrilho, F., Schmidt, W., Berg, T., McGarrity, T., Heathcote, E. J., Gonçales, F., Diago, M., Craxi, A., Silva, M., Bedossa, P., Mukhopadhyay, P., Griffel, L., Burroughs, M., Brass, C., & Albrecht, J. (2009). (In Press). Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. . Gastroenterology , 136 (5) , 1618-28.e2.
  • Shire, N. J., Rao, M. B., Succop, P., Buncher, C. R., Andersen, J. A., Butt, A. A., Chung, R. T., & Sherman, K. E. (2009). (In Press). Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. . Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association , 7 (4) , 471-80, 480.e1-2.
  • Atiq, M., Shire, N. J., Barrett, A., Rouster, S. D., Sherman, K. E., & Shata, M. T. (2009). (In Press). Hepatitis E virus antibodies in patients with chronic liver disease. . Emerging Infectious Diseases , 15 (3) , 479-81.
  • Gordon, S. C., & Sherman, K. E. (2009). (In Press). Treatment of HBV/HCV coinfection: releasing the enemy within. . Gastroenterology , 136 (2) , 393-6.
  • Kemmer, N., & Sherman, K. E. (2008). (In Press). What is the impact of HIV infection on survival after liver transplantation? . Nature Clinical Practice. Gastroenterology & Hepatology , 5 (8) , 426-7.
  • Blackard, J. T., Shata, M. T., Shire, N. J., & Sherman, K. E. (2008). (In Press). Acute hepatitis C virus infection: a chronic problem. . Hepatology (Baltimore, Md.) , 47 (1) , 321-31.
  • Sherman, K. E., Fleischer, R., Laessig, K., Murray, J., Tauber, W., & Birnkrant, D. (2007). (In Press). Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations. . Hepatology (Baltimore, Md.) , 46 (6) , 2014-20.
  • Sherman, K. E., Peters, M., & Koziel, M. J. (2007). (In Press). HIV and liver disease forum: conference proceedings. . Hepatology (Baltimore, Md.) , 45 (6) , 1566-77.
  • Alatrakchi, N., Graham, C. S., van der Vliet, H. J. J., Sherman, K. E., Exley, M. A., & Koziel, M. J. (2007). (In Press). Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. . Journal of Virology , 81 (11) , 5882-92.
  • Sherman, K. E., Goodman, Z. D., Sullivan, S. T., & Faris-Young, S. (2007). (In Press). Liver biopsy in cirrhotic patients. . The American Journal of Gastroenterology , 102 (4) , 789-93.
  • Blackard, J. T., Kang, M., St Clair, J. B., Lin, W., Kamegaya, Y., Sherman, K. E., Koziel, M. J., Peters, M. G., Andersen, J., & Chung, R. T. (2007). (In Press). Viral factors associated with cytokine expression during HCV/HIV co-infection. . Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research , 27 (4) , 263-9.
  • Shire, N. J., Rouster, S. D., Stanford, S. D., Blackard, J. T., Martin, C. M., Fichtenbaum, C. J., & Sherman, K. E. (2007). (In Press). The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. . Journal of Acquired Immune Deficiency Syndromes (1999) , 44 (3) , 309-14.
  • Blackard, J. T., & Sherman, K. E. (2007). (In Press). Hepatitis C virus coinfection and superinfection. . The Journal of Infectious Diseases , 195 (4) , 519-24.
  • Sherman, Kenneth E (2007). (In Press). New paradigms in the management of hepatitis C virus co-infections. . Nature Clinical Practice. Gastroenterology & Hepatology , 4 Suppl 1 , S10-6.
  • Shire, N. J., Horn, P. S., Rouster, S. D., Stanford, S., Eyster, M. E., & Sherman, K. E. (2006). (In Press). HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. . Hepatology (Baltimore, Md.) , 44 (5) , 1146-57.
  • Peters, M. G., Andersen, J., Lynch, P., Liu, T., Alston-Smith, B., Brosgart, C. L., Jacobson, J. M., Johnson, V. A., Pollard, R. B., Rooney, J. F., Sherman, K. E., Swindells, S., & Polsky, B. (2006). (In Press). Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. . Hepatology (Baltimore, Md.) , 44 (5) , 1110-6.
  • Blackard, J. T., Kang, M., Sherman, K. E., Koziel, M. J., Peters, M. G., & Chung, R. T. (2006). (In Press). Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. . Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research , 26 (11) , 834-8.
  • Mann, E. A., Stanford, S., & Sherman, K. E. (2006). (In Press). Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. . Virus Research , 121 (1) , 51-7.
  • Schwarze-Zander, C., Blackard, J. T., Zheng, H., Addo, M. M., Lin, W., Robbins, G. K., Sherman, K. E., Zdunek, D., Hess, G., & Chung, R. T. (2006). (In Press). GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. . The Journal of Infectious Diseases , 194 (4) , 410-9.
  • Blackard, J. T., Kemmer, N., & Sherman, K. E. (2006). (In Press). Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. . Hepatology (Baltimore, Md.) , 44 (1) , 15-22.
  • Atiq, M., Neff, G. W., Buell, J., Kemmer, N., Rudich, S., Weber, F., & Sherman, K. (2006). (In Press). Rhabdomylysis transference during liver transplantation. . Transplantation , 81 (9) , 1359-60.
  • Mandac, J. C., Chaudhry, S., Sherman, K. E., & Tomer, Y. (2006). (In Press). The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. . Hepatology (Baltimore, Md.) , 43 (4) , 661-72.
  • Graham, C. S., Wells, A., Liu, T., Sherman, K. E., Peters, M., Chung, R. T., Bhan, A. K., Andersen, J., & Koziel, M. J. (2006). (In Press). Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. . AIDS (London, England) , 20 (3) , 345-51.
  • Mrus, J. M., Sherman, K. E., Leonard, A. C., Sherman, S. N., Mandell, K. L., & Tsevat, J. (2006). (In Press). Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? . Medical Care , 44 (2) , 158-66.
  • Shire, N. J., Welge, J. A., & Sherman, K. E. (2006). (In Press). Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. . Vaccine , 24 (3) , 272-9.
  • Sherman, K. E., Shire, N. J., Cernohous, P., Rouster, S. D., Omachi, J. H., Brun, S., & Da Silva, B. (2005). (In Press). Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 41 (8) , 1186-95.
  • Sherman, Kenneth E (2005). (In Press). Treatment of hepatitis C virus and human immunodeficiency virus co-infection. . Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association , 3 (10 Suppl 2) , S118-21.
  • Chun, S., & Sherman, K. E. (2005). (In Press). Treatment of hepatitis C virus/HIV coinfection. . Clinics in Liver Disease , 9 (3) , 525-33, ix.
  • Shire, N. J., & Sherman, K. E. (2005). (In Press). Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 41 Suppl 1 , S63-8.
  • Graham, C. S., Wells, A., Liu, T., Sherman, K. E., Peters, M., Chung, R. T., Bhan, A. K., Andersen, J., & Koziel, M. J. (2005). (In Press). Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. . AIDS (London, England) , 19 (8) , 767-73.
  • Alatrakchi, N., Graham, C. S., He, Q., Sherman, K. E., & Koziel, M. J. (2005). (In Press). CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. . The Journal of Infectious Diseases , 191 (5) , 702-9.
  • Glesby, M. J., Bassett, R., Alston-Smith, B., Fichtenbaum, C., Jacobson, E. L., Brass, C., Owens, S., Sulkowski, M., Race, E. M., & Sherman, K. E. (2005). (In Press). Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. . The Journal of Infectious Diseases , 191 (5) , 686-93.
  • Lienesch, D., Morris, R., Metzger, A., Debuys, P., & Sherman, K. (2005). (In Press). Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. . The Journal of Rheumatology , 32 (3) , 489-93.
  • Sherman, K. E., Shire, N. J., Rouster, S. D., Peters, M. G., James Koziel, M., Chung, R. T., & Horn, P. S. (2005). (In Press). Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. . Gastroenterology , 128 (2) , 313-27.
  • Qin, H., Shire, N. J., Keenan, E. D., Rouster, S. D., Eyster, M. E., Goedert, J. J., Koziel, M. J., & Sherman, K. E. (2005). (In Press). HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. . Blood , 105 (2) , 533-41.
  • Shire, N. J., & Sherman, K. E. (2005). (In Press). Management of HBV/HIV-coinfected Patients. . Seminars in Liver Disease , 25 Suppl 1 , 48-57.
  • Sherman, K. E., Sherman, S. N., Chenier, T., & Tsevat, J. (2004). (In Press). Health values of patients with chronic hepatitis C infection. . Archives of Internal Medicine , 164 (21) , 2377-82.
  • Zucker, S. D., Horn, P. S., & Sherman, K. E. (2004). (In Press). Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. . Hepatology (Baltimore, Md.) , 40 (4) , 827-35.
  • Morelli, M. S., Rouster, S. D., Giannella, R. A., & Sherman, K. E. (2004). (In Press). Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. . Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association , 2 (8) , 669-74.
  • Keenan, E. D., Rouster, S. D., Shire, N. J., Horn, P. S., & Sherman, K. E. (2004). (In Press). Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. . The Journal of Infectious Diseases , 190 (3) , 511-4.
  • Chung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., Colquhoun, D., Nevin, T., Harb, G., & van der Horst, C. (2004). (In Press). Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. . The New England Journal of Medicine , 351 (5) , 451-9.
  • Graham, C. S., Curry, M., He, Q., Afdhal, N., Nunes, D., Fleming, C., Horsburgh, R., Craven, D., Sherman, K. E., & Koziel, M. J. (2004). (In Press). Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. . Hepatology (Baltimore, Md.) , 40 (1) , 125-32.
  • Shire, N. J., Rouster, S. D., Rajicic, N., & Sherman, K. E. (2004). (In Press). Occult hepatitis B in HIV-infected patients. . Journal of Acquired Immune Deficiency Syndromes (1999) , 36 (3) , 869-75.
  • Zucker, S. D., & Sherman, K. E. (2004). (In Press). Beyond interferon for hepatitis C: living in the present while hoping for the future. . Gastroenterology , 126 (5) , 1487-8.
  • Fleischer, R., Boxwell, D., & Sherman, K. E. (2004). (In Press). Nucleoside analogues and mitochondrial toxicity. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 38 (8) , e79-80.
  • Blackard, J. T., Yang, Y., Bordoni, P., Sherman, K. E., & Chung, R. T. (2004). (In Press). Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. . The Journal of Infectious Diseases , 189 (8) , 1472-81.
  • Sherman, Kenneth E (2004). (In Press). HCV and HIV: a tale of two viruses. . Reviews in Gastroenterological Disorders , 4 Suppl 1 , S48-54.
  • Shiramizu, B., Theodore, D., Bassett, R., Coel, M., Sherman, K. E., Glesby, M. J., Chow, D., Alston, B., Colquhoun, D., Merigan, T. C., Reichman, R. C., Berggren, R., Burning, W. J., & Brobst, S. (2003). (In Press). Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. . Journal of Acquired Immune Deficiency Syndromes (1999) , 33 (3) , 329-35.
  • Keiserman, D. R., Both, C. T., Mattos, A. A., Remiao, J., Alexandre, C. O. P., & Sherman, K. E. (2003). (In Press). Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. . The American Journal of Gastroenterology , 98 (4) , 878-83.
  • Sherman, Kenneth E (2003). (In Press). Implications of peginterferon use in special populations infected with HCV. . Seminars in Liver Disease , 23 Suppl 1 , 47-52.
  • Chung, R. T., Evans, S. R., Yang, Y., Theodore, D., Valdez, H., Clark, R., Shikuma, C., Nevin, T., & Sherman, K. E. (2002). (In Press). Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. . AIDS (London, England) , 16 (14) , 1915-23.
  • Goedert, J. J., Eyster, M. E., Lederman, M. M., Mandalaki, T., De Moerloose, P., White, G. C., Angiolillo, A. L., Luban, N. L. C., Sherman, K. E., Manco-Johnson, M., Preiss, L., Leissinger, C., Kessler, C. M., Cohen, A. R., DiMichele, D., Hilgartner, M. W., Aledort, L. M., Kroner, B. L., Rosenberg, P. S., & Hatzakis, A. (2002). (In Press). End-stage liver disease in persons with hemophilia and transfusion-associated infections. . Blood , 100 (5) , 1584-9.
  • Sherman, K. E., Rouster, S. D., & Horn, P. S. (2002). (In Press). Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 35 (4) , 482-7.
  • Ajayi, T., Sherman, K., & Tang, Q. (2002). (In Press). Support of marine sustainability science. . Science (New York, N.Y.) , 297 (5582) , 772.
  • Bleau, B. L., Gostout, C. J., Sherman, K. E., Shaw, M. J., Harford, W. V., Keate, R. F., Bracy, W. P., & Fleischer, D. E. (2002). (In Press). Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. . Gastrointestinal Endoscopy , 56 (1) , 1-6.
  • Sherman, Kenneth E (2002). (In Press). Diagnosis and management of the HCV/HIV-coinfected patient. . AIDS Clinical Care , 14 (5) , 39-43, 48.
  • Sherman, K. E., Rouster, S. D., Chung, R. T., & Rajicic, N. (2002). (In Press). Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 34 (6) , 831-7.

    Research Grants:

  • 5 U01 AI052748 NIH/NIAID. Solid Organ Transplantation in HIV: A Multi Site Study The major goals of this project are to evaluate the impact of immunosuppression in HIV positive liver and kidney transplant recipients on patient survival and to evaluate the impact of HIV infection and HAART on graft survival, PI
  • 5 U01 AI052748 NIH/NIAID. Pilot Study - HEV in HIV-Infected Liver Transplant Recipients The major goal of this project is to characterize the prevalence and incidence of HEV infection in potential HIV-infected liver and kidney transplant patients using samples collected from the Solid Organ Transplantation in HIV study., PI
  • 5 U01 AI69513 NIH/NIAID. AIDS Clinical Trials Group (ACTG) The major goals of this project are to design, conduct and analyze clinical trials to treat HIV disease and to treat/prevent its associated complications., Co-I
  • 2 K24 DK 070528 NIH/NIDDK. Mentorship in Liver Disease The major goals of this project are to provide mentorship and guidance to young investigators in liver research.
  • 5 R01 AI065256 NIH/NIAID. Antiretroviral Therapy and the Hepatitis C Virus The major goals of this proposed project are to develop and perform a clinical intervention trial in HCV/HIV coinfected subjects treated with ART in order to characterize early/late HCV and HIV viral kinetics as well as the prevalence, significance, and pathogenesis of HCV viral load increase.
  • 5 R13 AI071925 NIH/NIAID, NIDDK, NIDA, NIAAA. Liver Disease and HIV Conference The major goal of this project is to continue the development of a national conference to present current and relevant data that promotes understanding of liver disease in the setting of HIV infection.
  • 5 R21 AI081564 NIH/NIAID. Clinical Relevance of GB Virus C Interactions with HIV and Hepatitis C Virus in High Risk Women The major goals of this project are to determine the role of GBV-C co-infection on HIV disease progression in women, as well as evaluate the role of GBV-C genotype in HIV disease., Co-I
  • 1 R13 AI071925-01 National Institute of Allergy and Infectious Diseases. Liver Disease and HIV Conference, PI, Closed.
  • 3563sc / U01 AI052748 National Institute of Allergy and Infectious Diseases. Solid Organ Transplantation in HIV: A Multi-Site Study, PI, Closed.
  • National Institute of Allergy and Infectious Diseases. Social and Scientific Systems AACTG27.UCINN, PI, Closed.
  • 1-N01-CP-01004-01-A0-S0-E0 National Cancer Institute. Evolution of HIV-1 env in HIV-1-infected Individuals With and Without HCV Coinfection, PI, Closed.
  • K24 DK070528 National Inst of Diabetes and Digestive and Kidney Disease. Mentorship in Liver Disease, PI, Closed.
  • R01 AI065256 National Institute of Allergy and Infectious Diseases. Antiretroviral Therapy and the Hepatitis C Virus, PI, Active.
  • National Institute of Allergy and Infectious Diseases. HCV Genomic Variability in HIV Infected Hemophiliacs, PI, Closed.
  • 5-U01-AI-38858-06-A0-S0-E0 National Institute of Allergy and Infectious Diseases. Adult ACTG Central Group, PI, Closed.
  • 2002-UC-14-01-A0-S0-E0 Social & Scientific Systems, Inc.. Social Scientific Systems AACTG.27.NW205.01, PI, Closed.
  • 5-97-CY-50391-02-A0-S0-E0 National Cancer Institute. HCV Quasispecies Variability in HIV/HCV Co-Infected, PI, Closed.
  • 1-U01-AI-38858-01-A0-S0-E0 National Institute of Allergy and Infectious Diseases. Prevalence of Hepatitis C Virus (HCV) and Distribution of Genotypes in a Representative ACTG Cohort, PI, Closed.
  • R03HS10366-01-A0-S0-E0 Agency for Healthcare Research and Quality. Health Utilities in Hepatitis C Infected Patients, PI, Closed.
  • R13 AI071925 National Institute of Allergy and Infectious Diseases. Liver Disease and HIV, PI, Closed.
  • R21 AI081564 National Institute of Allergy and Infectious Diseases. Clinical Relevance of GB Virus C Interactions with HIV and Hepatitis C Virus in High Risk Women, Collaborator, Closed.
  • 3 K24 DK070528-05S1 National Inst of Diabetes and Digestive and Kidney Disease. Mentorship in Liver Disease, PI, Closed.
  • K24 DK070528 National Inst of Diabetes and Digestive and Kidney Disease. Mentorship in Liver Disease, PI, Active.
  • Merck 38879 Merck Sharp & Dohme Corp. Exploring the Role of Gut-associated Th17 in Microbial Translocation in HIV and HCV/HIV Coinfected Patients, Collaborator, Closed.
  • SRS 007663 Merck Sharp & Dohme Corp. The Cost Effectiveness of Screening for Chronic Hepatitis C Infection in the United States, PI, Active.
  • SRS 007747 Bristol-Myers Squibb Co.. Development of Novel Methodologies for the Detection of IL28B Single-Nucleotide Polymorphisms in HCV-Infected Patients, PI, Active.
  • SRS 007837 Merck Sharp & Dohme Corp. Evaluating the Role of the Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy, Collaborator, Active.
  • R13AI071925 National Institute of Allergy and Infectious Diseases. Liver Disease and HIV, PI, Active.
  • BRS-ACURE-S-12-000068-002483 / UM1 AI068636-06 National Institute of Allergy and Infectious Diseases. A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects, PI, Closed.
  • BRS-ACURE-S-12-002522 Merck & Co., Inc.. ACTG Protocol A5294 - BIRTH - A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects, PI, Active.
  • R34HL109334 National Heart, Lung and Blood Institute. Viral Kinetic Models of HCV Clearance in Hemophiliacs Treated with Telaprevir, PI, Active.
  • Req No. 2715199 HHSN272201200811P National Institute of Allergy and Infectious Diseases. The Use of Chemokine Receptor 5 (CCR5) Blockade Using a Monoclonal Antibody to Reverse Liver Fibrosis in HIV-infected Subjects, PI, Active.
  • 108400 \ UM1A1068636 National Institute of Allergy and Infectious Diseases. Characterization of HCV Resistance Associated Variants in Liver Tissue, PI, Active.
  • U01FD004573 Food and Drug Administration. Pharmacokinetic Studies of Tacrolimus in Transplant Patients, Collaborator, Active.
  • 108269/AI068636 National Institute of Allergy and Infectious Diseases. Protocol A5294 BIRTH - A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b And Ribavirin In HCV/HIV Coinfected Subjects, PI, Active.
  • AI463-980 Bristol-Myers Squibb Co.. Hepatitis C Virus Prevalence: Role of the Emergency Department in Screening, PI, Active.
  • PRO12060248 (HOTS) Health Resources and Services Administration. Hemophilia Liver Transplant Observational (HOT) Study, PI, Awarded.
  • 110237 / AI068636-08 National Institute of Allergy and Infectious Diseases. AIDS Clinical Trial Group Network - Co-Chair on ACTG Protocol A5294, PI, Active.
  • R56 AI065256 National Institute of Allergy and Infectious Diseases. Antiretroviral Therapy and Hepatic Injury, PI, Awarded.

Recent Awards/Honors:

  • Sigma Xi (National Research Honor Society), 1979
  • Alpha Zeta (National Agricultural Honor Society), 1976
  • Busch Pre-doctoral Fellow at the Waksman Institute for Microbiology, 1976,1980
  • B.S. with High Honors (Magna Cum), 1976
  • George Washington University Donald Glew Medical Student Research Award, 1985
  • Army Achievement Medal (Research Activities), 1989
  • William Beaumont Award for Clinical Research in Gastroenterology, 1989
  • Army Meritorious Service Medal, 1994
  • Who's Who in America 59th Edition, 2005
  • Best Doctors in America, 2005,2010
  • Alpha Omega Alpha (AOA)
CARE/Crawley Building

More Information


For more information on the UC Department of Internal Medicine, please contact us at:

UC Department of Internal Medicine
231 Albert Sabin Way
Medical Sciences Building Room 6065
PO Box 670557
Cincinnati, OH 45267-0557

Phone: 513-558-4231
Fax: 513-558-0852
Email: ucintmed@uc.edu